ProfileGDS4718 / 201870_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 84% 79% 85% 83% 97% 97% 86% 82% 81% 85% 83% 92% 97% 92% 84% 82% 95% 90% 85% 87% 86% 82% 84% 84% 95% 82% 95% 82% 93% 90% 93% 83% 82% 96% 96% 92% 84% 84% 80% 84% 96% 94% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4767385
GSM549102patient 115, normal, homogenized [OPG study]8.2700784
GSM549104patient 119, normal, homogenized [OPG study]7.8513779
GSM549108patient 138, normal, homogenized [OPG study]8.3331185
GSM549119patient 077, normal, homogenized [OPG study]8.2007783
GSM549133patient 032, cancer, homogenized [OPG study]10.797297
GSM549139patient 042, cancer, homogenized [OPG study]10.727297
GSM549099patient 107, normal, homogenized [OPG study]8.5378386
GSM549109patient 139, normal, homogenized [OPG study]8.052482
GSM549110patient 046, normal, homogenized [OPG study]7.9173381
GSM549114patient 063, normal, homogenized [OPG study]8.55485
GSM549122patient 082, normal, homogenized [OPG study]8.1740783
GSM549134patient 033, cancer, homogenized [OPG study]9.526292
GSM549136patient 036, cancer, homogenized [OPG study]10.881997
GSM549140patient 044, cancer, homogenized [OPG study]9.5425992
GSM549111patient 047, normal, homogenized [OPG study]8.3895684
GSM549113patient 057, normal, homogenized [OPG study]8.1734182
GSM549132patient 031, cancer, homogenized [OPG study]10.10195
GSM549137patient 038, cancer, homogenized [OPG study]9.1992290
GSM549142patient 047, cancer, homogenized [OPG study]8.0781985
GSM549100patient 110, normal, homogenized [OPG study]8.7075587
GSM549107patient 135, normal, homogenized [OPG study]8.6890686
GSM549115patient 068, normal, homogenized [OPG study]8.1897582
GSM549116patient 072, normal, homogenized [OPG study]8.3924884
GSM549120patient 078, normal, homogenized [OPG study]8.3630484
GSM549131patient 030, cancer, homogenized [OPG study]10.278695
GSM549118patient 074, normal, homogenized [OPG study]8.1575682
GSM549129patient 027, cancer, homogenized [OPG study]10.056695
GSM549123patient 088, normal, homogenized [OPG study]8.1506982
GSM549124patient 006, cancer, homogenized [OPG study]9.6166793
GSM549126patient 015, cancer, homogenized [OPG study]9.2019390
GSM549128patient 025, cancer, homogenized [OPG study]9.7677193
GSM549103patient 117, normal, homogenized [OPG study]8.1094483
GSM549117patient 073, normal, homogenized [OPG study]8.1053182
GSM549138patient 041, cancer, homogenized [OPG study]10.565196
GSM549141patient 045, cancer, homogenized [OPG study]10.40796
GSM549130patient 028, cancer, homogenized [OPG study]9.4017492
GSM549101patient 111, normal, homogenized [OPG study]8.3366884
GSM549105patient 128, normal, homogenized [OPG study]8.259584
GSM549106patient 134, normal, homogenized [OPG study]7.9891280
GSM549112patient 048, normal, homogenized [OPG study]8.3536784
GSM549125patient 011, cancer, homogenized [OPG study]10.51596
GSM549127patient 024, cancer, homogenized [OPG study]9.7689894
GSM549135patient 035, cancer, homogenized [OPG study]10.910497